C M Bidwell & Associates Ltd. bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,804 shares of the medical device company’s stock, valued at approximately $168,000. Other large investors also recently […]